Yu N - Search Results

1

Effectiveness and safety of upadacitinib in patients with face and neck atopic dermatitis unresponsive to dupilumab.

Yang Y, Chen J, Yu N, Ke Y, Gao A, Xiong S, Zhao X, Liu Y, Zhu H. Yang Y, et al. Among authors: yu n. J Dermatolog Treat. 2023 Dec;34(1):2242540. doi: 10.1080/09546634.2023.2242540. J Dermatolog Treat. 2023. PMID: 37526019 Free article. No abstract available.

2

Efficacy of low-fluence 1064 nm Q-switched Nd: YAG laser for the treatment of melasma: A meta-analysis and systematic review.

Chen J, Yu N, Peng L, Li H, Tang Y, Ou S, Zhu H. Chen J, et al. Among authors: yu n. J Cosmet Dermatol. 2022 Jul;21(7). doi: 10.1111/jocd.15126. Epub 2022 Jun 4. J Cosmet Dermatol. 2022. PMID: 35621242 Review.

3

Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo.

Chen J, Yu N, Li H, Tang Y, Zhu H. Chen J, et al. Among authors: yu n. J Int Med Res. 2022 Sep;50(9):3000605221119646. doi: 10.1177/03000605221119646. J Int Med Res. 2022. PMID: 36062405 Free PMC article.

4

T-Cell Lymphoblastic Lymphoma with Cutaneous Involvement in a Child: A Rare Case Report.

Chen J, Tian X, Yu N, Peng L, Zhu H. Chen J, et al. Among authors: yu n. Clin Cosmet Investig Dermatol. 2022 Sep 23;15:2027-2033. doi: 10.2147/CCID.S376523. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36176942 Free PMC article.

5

Successful Treatment of Severe Subcorneal Pustular Dermatosis with Adalimumab.

Chen J, Luo Y, Yu N, Yang Y, Zhou X, Zhang S, Ye Q, Zhu H. Chen J, et al. Among authors: yu n. Clin Cosmet Investig Dermatol. 2022 Nov 28;15:2567-2570. doi: 10.2147/CCID.S391594. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36466943 Free PMC article.

6

Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma.

Chen J, Yu N, Ou S, Wang X, Li H, Zhu H. Chen J, et al. Among authors: yu n. J Cancer Res Clin Oncol. 2023 Oct;149(13):11619-11634. doi: 10.1007/s00432-023-05064-8. Epub 2023 Jul 4. J Cancer Res Clin Oncol. 2023. PMID: 37401939

7

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series.

Chen J, Yu N, Wu W, Ou S, Chen Q, Zhu H. Chen J, et al. Among authors: yu n. Clin Cosmet Investig Dermatol. 2023 Aug 29;16:2357-2363. doi: 10.2147/CCID.S422683. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37663886 Free PMC article.

8

Tanshinone Alleviates UVA-induced Melanogenesis in Melanocytes via the Nrf2-regulated Antioxidant Defense Signaling Pathway.

Chen J, Yin Z, Yu N, Ou S, Wang X, Li H, Zhu H. Chen J, et al. Among authors: yu n. Curr Mol Med. 2024;24(12):1529-1539. doi: 10.2174/0115665240263196230920161019. Curr Mol Med. 2024. PMID: 37921187

9

Carving Metal-Organic-Framework Glass Based Solid-State Electrolyte Via a Top-Down Strategy for Lithium-Metal Battery.

Xiang Y, Yu N, Li J, Xu H, Chen S, Xia Y, Luo Z, Li X, Liu Z, Xu M, Jiang Y, Zhang X. Xiang Y, et al. Among authors: yu n. Angew Chem Int Ed Engl. 2025 Jan 20:e202424288. doi: 10.1002/anie.202424288. Online ahead of print. Angew Chem Int Ed Engl. 2025. PMID: 39831898

10

Oral Akkermansia muciniphila Biomimetic Nanotherapeutics for Ulcerative Colitis Targeted Treatment by Repairing Intestinal Epithelial Barrier and Restoring Redox Homeostasis.

Zhang Q, Peng L, Zhang Q, Guo J, Yu N, Yang J, Zuo W. Zhang Q, et al. Among authors: yu n. ACS Appl Mater Interfaces. 2025 Jan 16. doi: 10.1021/acsami.4c18301. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39817352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,606 results

Search Page

Filters